APO-TRAVOPROST DIN 02489775
Health Canada record
| Active ingredient(s) | TRAVOPROST 0.003 % |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01EE04 TRAVOPROST |
| Original market date | |
| Current status date | 01-Jun-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRAVOPROST
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02458691 | APO-TRAVOPROST-TIMOLOL PQ | APOTEX INC | Solution | TRAVOPROST 0.004 %; TIMOLOL (TIMOLOL MALEATE) 0.5 % | Approved |
| 02415305 | APO-TRAVOPROST-TIMOP PQ | APOTEX INC | Solution | TRAVOPROST 0.004 %; TIMOLOL (TIMOLOL MALEATE) 0.5 % | Marketed |
| 02278251 | DUOTRAV PQ | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | TRAVOPROST 0.004 %; TIMOLOL (TIMOLOL MALEATE) 0.5 % | Marketed |
| 02457997 | IZBA | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | TRAVOPROST 0.003 % | Marketed |
| 02548089 | JAMP TRAVOPROST Z | JAMP PHARMA CORPORATION | Solution | TRAVOPROST 0.004 % | Marketed |
| 02413167 | SANDOZ TRAVOPROST | SANDOZ CANADA INCORPORATED | Solution | TRAVOPROST 0.004 % | Marketed |
| 02318008 | TRAVATAN Z | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | TRAVOPROST 0.004 % | Marketed |
| 02415739 | APO-TRAVOPROST Z | APOTEX INC | Solution | TRAVOPROST 0.004 % | Dormant |
| 02428121 | MYLAN-TRAVOPROST Z | MYLAN PHARMACEUTICALS ULC | Solution | TRAVOPROST 0.004 % | Cancelled Pre Market |
| 02424479 | PMS-TRAVOPROST Z | PHARMASCIENCE INC | Solution | TRAVOPROST 0.004 % | Cancelled Pre Market |
| 02413817 | SANDOZ TRAVOPROST / TIMOLOL PQ | SANDOZ CANADA INCORPORATED | Solution | TRAVOPROST 0.004 %; TIMOLOL (TIMOLOL MALEATE) 0.5 % | Cancelled Pre Market |
| 02412063 | TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | TEVA CANADA LIMITED | Solution | TRAVOPROST 0.004 % | Cancelled Post Market |
| 02244896 | TRAVATAN | ALCON CANADA INC | Solution | TRAVOPROST 0.004 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23694 | 2020-06-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for TRAVOPROST
14 active FDA Drug Master Files.
Request a quote for APO-TRAVOPROST